Silverfin false false 31/03/2025 01/04/2024 31/03/2025 A Buckhalter 31/07/2020 E Buckhalter 31/07/2020 31 July 2025 The principal activity of the Company during the financial period was that of an investment company. 12782514 2025-03-31 12782514 bus:Director1 2025-03-31 12782514 bus:Director2 2025-03-31 12782514 2024-03-31 12782514 core:CurrentFinancialInstruments 2025-03-31 12782514 core:CurrentFinancialInstruments 2024-03-31 12782514 core:Non-currentFinancialInstruments 2025-03-31 12782514 core:Non-currentFinancialInstruments 2024-03-31 12782514 core:ShareCapital 2025-03-31 12782514 core:ShareCapital 2024-03-31 12782514 core:RetainedEarningsAccumulatedLosses 2025-03-31 12782514 core:RetainedEarningsAccumulatedLosses 2024-03-31 12782514 core:OtherPropertyPlantEquipment 2024-03-31 12782514 core:OtherPropertyPlantEquipment 2025-03-31 12782514 core:CostValuation 2024-03-31 12782514 core:AdditionsToInvestments 2025-03-31 12782514 core:DisposalsRepaymentsInvestments 2025-03-31 12782514 core:RevaluationsIncreaseDecreaseInInvestments 2025-03-31 12782514 core:CostValuation 2025-03-31 12782514 bus:OrdinaryShareClass1 2025-03-31 12782514 bus:OrdinaryShareClass2 2025-03-31 12782514 bus:OrdinaryShareClass3 2025-03-31 12782514 2024-04-01 2025-03-31 12782514 bus:FilletedAccounts 2024-04-01 2025-03-31 12782514 bus:SmallEntities 2024-04-01 2025-03-31 12782514 bus:AuditExemptWithAccountantsReport 2024-04-01 2025-03-31 12782514 bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 12782514 bus:Director1 2024-04-01 2025-03-31 12782514 bus:Director2 2024-04-01 2025-03-31 12782514 core:OtherPropertyPlantEquipment core:TopRangeValue 2024-04-01 2025-03-31 12782514 2023-04-01 2024-03-31 12782514 core:OtherPropertyPlantEquipment 2024-04-01 2025-03-31 12782514 bus:OrdinaryShareClass1 2024-04-01 2025-03-31 12782514 bus:OrdinaryShareClass1 2023-04-01 2024-03-31 12782514 bus:OrdinaryShareClass2 2024-04-01 2025-03-31 12782514 bus:OrdinaryShareClass2 2023-04-01 2024-03-31 12782514 bus:OrdinaryShareClass3 2024-04-01 2025-03-31 12782514 bus:OrdinaryShareClass3 2023-04-01 2024-03-31 iso4217:GBP xbrli:pure xbrli:shares

Company No: 12782514 (England and Wales)

THE MYSTERY BAYLEAF LIMITED

Unaudited Financial Statements
For the financial year ended 31 March 2025
Pages for filing with the registrar

THE MYSTERY BAYLEAF LIMITED

Unaudited Financial Statements

For the financial year ended 31 March 2025

Contents

THE MYSTERY BAYLEAF LIMITED

STATEMENT OF FINANCIAL POSITION

As at 31 March 2025
THE MYSTERY BAYLEAF LIMITED

STATEMENT OF FINANCIAL POSITION (continued)

As at 31 March 2025
Note 2025 2024
£ £
Fixed assets
Tangible assets 3 2,689 2,677
Investments 4 1,251,019 1,376,175
1,253,708 1,378,852
Current assets
Debtors
- due within one year 5 2,637 0
- due after more than one year 5 8,887 24,947
Cash at bank and in hand 22,404 120,724
33,928 145,671
Creditors: amounts falling due within one year 6 ( 1,159,774) ( 1,403,138)
Net current liabilities (1,125,846) (1,257,467)
Total assets less current liabilities 127,862 121,385
Net assets 127,862 121,385
Capital and reserves
Called-up share capital 7 1,000 1,000
Profit and loss account 126,862 120,385
Total shareholders' funds 127,862 121,385

For the financial year ending 31 March 2025 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The financial statements of The Mystery Bayleaf Limited (registered number: 12782514) were approved and authorised for issue by the Board of Directors on 31 July 2025. They were signed on its behalf by:

A Buckhalter
Director
THE MYSTERY BAYLEAF LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 March 2025
THE MYSTERY BAYLEAF LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 March 2025
1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial year, unless otherwise stated.

General information and basis of accounting

The Mystery Bayleaf Limited (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is 1-3 College Yard, Worcester, WR1 2LB, United Kingdom.

The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

Going concern

The directors have assessed the Statement of Financial Position and likely future cash flows at the date of approving these financial statements. The directors note that the business has net current liabilities of £1,125,846. The Company is supported through loans from the directors. The directors have confirmed that the loan facilities will continue to be available for at least 12 months from the date of signing these financial statements and the directors will continue to support the Company. Given the current position, the directors believe that any foreseeable debts can be met for at least 12 months from the date of signing these financial statements. Accordingly, they continue to adopt the going concern basis in preparing the financial statements.

Interest income

Interest income is recognised when it is probable that the economic benefits will flow to the Company and the amount of revenue can be measured reliably. Interest income is accrued on a time basis, by reference to the principal outstanding at the effective interest rate applicable, which is the rate that exactly discounts estimated future cash receipts through the expected life of the financial asset to that asset's net carrying amount on initial recognition.

Dividend income

Dividend income from investments is recognised when the shareholders' rights to receive payment have been established (provided that it is probable that the economic benefits will flow to the Company and the amount of revenue can be measured reliably).

Taxation

Current tax
Current tax is provided at amounts expected to be paid (or recoverable) using the tax rates and laws that have been enacted or substantively enacted at the Statement of Financial Position date.

Deferred tax
Deferred tax arises as a result of including items of income and expenditure in taxation computations in periods different from those in which they are included in the Company's financial statements. Deferred tax is provided in full on timing differences which result in an obligation to pay more or less tax at a future date, at the average tax rates that are expected to apply when the timing differences reverse, based on current tax rates and laws. Deferred tax assets and liabilities are not discounted.

The carrying amount of deferred tax assets are reviewed at each reporting date and a valuation allowance is set up against deferred tax assets so that the net carrying amount equals the highest amount that is more likely than not to be recovered based on current or future taxable profit.

Tangible fixed assets

Tangible fixed assets are stated at cost (or deemed cost) or valuation less accumulated depreciation and accumulated impairment losses. Cost includes costs directly attributable to making the asset capable of operating as intended. Depreciation is provided on all tangible fixed assets, other than investment properties and freehold land, at rates calculated to write off the cost or valuation, less estimated residual value, of each asset on a straight-line basis over its expected useful life, as follows:

Plant and machinery etc. 3 years straight line
Fixed asset investments

Investments are recognised initially at fair value which is normally the transaction price excluding transaction costs. Subsequently, they are measured at fair value through profit or loss if the shares are publicly traded or their fair value can otherwise be measured reliably. Other investments are measured at cost less impairment.

Trade and other debtors

Trade and other debtors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest method less impairment losses for bad and doubtful debts, except where the effect of discounting would be immaterial. In such cases the receivables are stated at cost less impairment losses for bad and doubtful debts.

Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in creditors: amounts falling due within one year.

Trade and other creditors

Trade and other creditors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest rate method, unless the effect of discounting would be immaterial, in which case they are stated at cost.

Financial instruments

Financial assets and financial liabilities are recognised when the Company becomes a party to the contractual provisions of the instrument.

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Company after deducting all of its liabilities.

Financial assets and liabilities are only offset in the Balance Sheet when, and only when there exists a legally enforceable right to set off the recognised amounts and the Company intends either to settle on a net basis, or to realise the asset and settle the liability simultaneously.

Ordinary share capital

The ordinary share capital of the Company is presented as equity.

2. Employees

2025 2024
Number Number
Monthly average number of persons employed by the Company during the year, including directors 2 2

3. Tangible assets

Plant and machinery etc. Total
£ £
Cost
At 01 April 2024 7,382 7,382
Additions 1,553 1,553
At 31 March 2025 8,935 8,935
Accumulated depreciation
At 01 April 2024 4,705 4,705
Charge for the financial year 1,541 1,541
At 31 March 2025 6,246 6,246
Net book value
At 31 March 2025 2,689 2,689
At 31 March 2024 2,677 2,677

4. Fixed asset investments

Listed investments Total
£ £
Cost or valuation before impairment
At 01 April 2024 1,376,175 1,376,175
Additions 545,724 545,724
Disposals ( 667,717) ( 667,717)
Movement in fair value ( 3,163) ( 3,163)
At 31 March 2025 1,251,019 1,251,019
Carrying value at 31 March 2025 1,251,019 1,251,019
Carrying value at 31 March 2024 1,376,175 1,376,175

5. Debtors

2025 2024
£ £
Debtors: amounts falling due within one year
Other debtors 2,637 0
Debtors: amounts falling due after more than one year
Deferred tax asset 8,887 24,947

6. Creditors: amounts falling due within one year

2025 2024
£ £
Trade creditors 0 1,819
Other creditors 1,159,774 1,401,319
1,159,774 1,403,138

7. Called-up share capital

2025 2024
£ £
Allotted, called-up and fully-paid
400 Ordinary A shares of £ 1.00 each 400 400
400 Ordinary B shares of £ 1.00 each 400 400
200 Ordinary C shares of £ 1.00 each 200 200
1,000 1,000

8. Related party transactions

Transactions with the entity's directors

2025 2024
£ £
Amounts owed to directors 1,155,572 1,398,019

The loan from the directors remains interest-free and repayable on demand.